ONVO Projected Dividend Yield
Organovo Holdings Inc ( NASDAQ : ONVO )Organovo Holdings, Inc. is a clinical-stage biotechnology company. Co. is focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues, as well as preclinical data. Its segments include research and development (R&D) and Mosaic Cell Sciences (Mosaic). It is also focused on building high fidelity, 3D tissues that recapitulate key aspects of human disease. It uses its proprietary technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. 21 YEAR PERFORMANCE RESULTS |
ONVO Dividend History Detail ONVO Dividend News ONVO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |